Search EN menu
 
 Homepage

As an LGBTIQ inclusive employer, we celebrate the Luxembourg Pride Week.

See more  
en EIB GROUP CLIENT PORTAL
Close EIB GROUP CLIENT PORTAL
Search
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

HEAVY ION THERAPY AND R&D HEIDELBERG

Signature(s)

Amount
€ 66,000,000
Countries
Sector(s)
Germany : € 66,000,000
Health : € 66,000,000
Signature date(s)
16/07/2003 : € 18,000,000
17/03/2006 : € 48,000,000
Link to source
Data sheet
HEAVY ION THERAPY AND R&D HEIDELBERG
Other links
Summary sheet
Heavy ion therapy and R&D Heidelberg

Summary sheet

Release date
15 February 2002
Status
Reference
Signed | 16/07/2003
20010517
Project name
Promoter - financial intermediary
Heavy ion therapy and R&D Heidelberg
Universitätsklinikum Heidelberg and the Gesellschaft für Schwerionenforschung (GSI), Darmstadt
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 44 million
At least EUR 88 million
Location
Sector(s)
Description
Objectives

The project consists of establishing a facility at the Heidelberg University Hospital, combining carbon ion acceleration and advanced diagnostic imaging techniques into a state-of-the-art radiotherapy technology.

The project will contribute to enhancing the knowledge base and competitiveness of the EU healthcare industry.

Environmental aspects
Procurement

Compliance with EU environmental directives and national laws shall be ensured.

The promoter's procurement procedures will be examined during appraisal.

Comments

R&D and human health activities.

Link to source
Summary sheet
Heavy ion therapy and R&D Heidelberg
Other links
Data sheet
HEAVY ION THERAPY AND R&D HEIDELBERG

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

Related publications